Molina Healthcare (MOH) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
23 Jul, 2026Executive summary
Q2 2026 adjusted EPS was $1.51 and GAAP EPS was $1.19, both down over 74% year-over-year, with net income at $60 million, reflecting lower membership, premium revenue, higher MCR, and a $93 million impairment charge from the planned MAPD exit.
Full-year 2026 premium revenue guidance remains at ~$42B; adjusted EPS guidance raised by $0.25 to at least $5.25, driven by Medicaid outperformance.
Membership declined 14% year-over-year to 4.9 million, mainly due to Medicaid market contraction, contract expirations, and Marketplace losses.
Medicaid and Medicare duals segments delivered strong results, while Marketplace performance was negatively impacted by adverse member acuity mix and prior year risk adjustment items.
2026 is expected to be a trough year for Medicaid margins, with optimism for 2027 margin improvement as rate-setting incorporates recent trends.
Financial highlights
Q2 2026 premium revenue: $10.2B, down 6% year-over-year; total revenue: $10.87B.
Consolidated Q2 MCR: 92.2%, up from 90.4% in Q2 2025; Medicaid MCR: 92.7%; Medicare MCR: 90.7%; Marketplace MCR: 88.9%.
Operating income for Q2 2026 was $145M, down from $373M in Q2 2025; net income margin: 0.8%.
Operating cash flow for H1 2026: $788M; parent company cash at quarter-end: $290M.
Debt-to-capital ratio at quarter-end: 47%; S&P downgraded senior notes to BB- in April 2026.
Outlook and guidance
2026 premium revenue guidance unchanged at ~$42B; full-year adjusted EPS guidance raised to at least $5.25.
Medicaid enrollment expected to decrease to 4.5M by year-end 2026; Marketplace enrollment to 250,000.
2027 premium outlook revised to $46.5B (11% YoY growth), reflecting Marketplace reduction and California Medicaid changes.
2027 EPS building blocks sum to >$10/share, with embedded earnings and margin improvements expected.
2029 targets reaffirmed: $64B premium revenue and $25 EPS, predicated on MCR improvement, growth initiatives, and operating leverage.
Latest events from Molina Healthcare
- 2029 outlook: $64B premium, $25 EPS, margin recovery, and strong growth from RFPs and M&A.MOH
Investor Day 20268 May 2026 - Q1 2026 saw lower earnings and membership, but full-year guidance remains reaffirmed.MOH
Q1 202623 Apr 2026 - Proxy covers director elections, pay-for-performance, auditor ratification, and expanded shareholder rights.MOH
Proxy filing23 Mar 2026 - Key votes include director elections, executive pay, auditor ratification, and expanded shareholder rights.MOH
Proxy filing23 Mar 2026 - Key votes include director elections, pay, auditor, equity plan, and special meeting rights.MOH
Proxy Filing13 Mar 2026 - 2025 earnings fell short on cost pressures; 2026 outlook cautious with Medicare Part D exit ahead.MOH
Q4 20256 Feb 2026 - Premium revenue up 17%, adjusted EPS $5.86, and guidance reaffirmed for 2024.MOH
Q2 20243 Feb 2026 - Q3 premium revenue up 18% and GAAP EPS up 34%; guidance reaffirmed.MOH
Q3 202418 Jan 2026 - Targeting $52–$55B revenue and 13%–15% EPS growth by 2027 with strong margin discipline.MOH
Investor Day 202415 Jan 2026